Ongeno

Poland
Suchacz, Warmia-Masuria, Poland, 31-559

Company profile

Ongeno company profile

Ongeno is a medicinal technology developer meant for multiple autoimmune disease treatment. The company specializes in the use of stem cells in regenerative medicine and uses autologous bone marrow stem cells to treat multiple sclerosis.

Business identity

Contact email
[email protected]
Operating status
Active
Company type
For Profit
Employee range
1-10 employees
Founded
2017-01-01, Year

Headquarters

Postal code
31-559
Country code
PL
Continent
Europe

Capital profile

Funding and company signals

Funding rounds
1
Total equity funding
$3.6M
Last funding
Undisclosed / $3.6M / 2025-01-21
Last equity funding
Undisclosed / $3.6M

Founders and investors

No public relation records are available.